Kuei-Pin Huang
@kphuang_
A neuroscientist with a specific interest in feeding behavior, obesity, and gut-brain axis
ID: 4756331358
14-01-2016 05:04:08
34 Tweet
61 Followers
35 Following
Today in nature-- Monell Center researchers, led by AmberAlhadeff, share new findings that point towards a possible way to reduce adverse side effects of popular next-generation obesity medications like GLP1-based drugs, known as semaglutide and marketed as Ozempic® and Wegovy®
Refinement of our understanding of the distinct CNS pathways mediating reduction of food intake (in the hindbrain) vs aversive responses AmberAlhadeff Is selective targeting possible? nature.com/articles/s4158…
So pleased to have been able to contribute to this beautiful work from the AmberAlhadeff group: nature.com/articles/s4158…. Not all GLP1R neurons in the DVC are the same! Understanding this heterogeneity is critical for future obesity drug design.
Absolutely inspiring talk by Helen Raybould for her Distinguished Career Award. I am honored to have a trainee in common with her - Kuei-Pin Huang - who will be on the academic job market this fall!
As GLP-1 science expands beyond glucose control #T2D and #weightloss new indications are being explored in the clinic, highlighting potential roles for GLP-1 in neuroprotection, substance use disorders, metabolic liver disease and more Science Magazine science.org/doi/10.1126/sc…
Go check out this exciting g work from #MCIP alum Kuei-Pin Huang on the role GLP1 signaling in satiety versus aversion. Congrats to the team!
So happy to share our new work that is now out @sciencemagazine: We show how neurons in the mouse zona incerta (ZI) modulate infant social behaviors and learning. This work was led by the AMAZING graduate student Yuexuan Li Yuexuan Li 李玥璇. 🎉science.org/doi/epdf/10.11… #ScienceResearch